More about

Wet Age-Related Macular Degeneration

News
October 28, 2021
1 min watch
Save

VIDEO: Highlights in gene therapy for wet AMD from ASRS meeting

VIDEO: Highlights in gene therapy for wet AMD from ASRS meeting

Rishi P. Singh, MD, talked about gene therapy studies for neovascular age-related macular degeneration presented at the ASRS meeting in a video interview with Healio.

News
October 26, 2021
1 min watch
Save

VIDEO: Efficacy, safety of Port Delivery System in wet AMD

VIDEO: Efficacy, safety of Port Delivery System in wet AMD

Rishi P. Singh, MD, staff surgeon at Cole Eye Institute, Cleveland Clinic, and associate professor of ophthalmology at Lerner College of Medicine, discussed highlights in wet age-related macular degeneration from the ASRS meeting.

News
October 19, 2021
1 min read
Save

Promising results reported from Notal Home OCT feasibility study

A home-based OCT imaging study in patients with wet age-related macular degeneration demonstrated ease of use and good image quality, according to a press release from Notal Vision.

News
October 14, 2021
1 min read
Save

Applications for Beovu for DME treatment accepted in US, Europe, Japan

Applications for Beovu to treat diabetic macular edema have been accepted in the United States, Europe and Japan, according to a press release from Novartis.

News
October 09, 2021
6 min watch
Save

VIDEO: Pegcetacoplan well tolerated in DERBY, OAKS trials

VIDEO: Pegcetacoplan well tolerated in DERBY, OAKS trials

In this video from the Retina Society meeting, Charles Wykoff, MD, PhD, discusses results from the DERBY and OAKS trials investigating pegcetacoplan in patients with geographic atrophy secondary to age-related macular degeneration.

News
October 08, 2021
1 min read
Save

UBX1325 shows sustained responses in patients with DME, wet AMD at 12 weeks

Patients with diabetic macular edema or wet age-related macular degeneration who received a single injection of UBX1325 demonstrated “strong and sustained responses” at 12 weeks, according to a press release from Unity Biotechnology.

News
September 28, 2021
1 min read
Save

ONS-5010 for wet AMD shows positive 12-month safety data

Full-year results from a pivotal phase 3 trial confirm previously reported data demonstrating ONS-5010 was well tolerated and had no unanticipated safety signals, according to a press release from Outlook Therapeutics.

News
September 24, 2021
4 min read
Save

Consensus group redefines nonadherence, nonpersistence in neovascular AMD treatment

Consensus group redefines nonadherence, nonpersistence in neovascular AMD treatment

A group of retina specialists developed and published a new consensus-based classification system for nonadherence and nonpersistence to anti-VEGF therapies in neovascular age-related macular degeneration.

News
September 20, 2021
1 min read
Save

FDA approves Byooviz, first ophthalmology biosimilar

FDA approves Byooviz, first ophthalmology biosimilar

The FDA has approved Byooviz as a biosimilar to Lucentis for the treatment of some retinal diseases and conditions, including wet age-related macular degeneration, according to a press release from Samsung Bioepis and Biogen.

News
September 16, 2021
1 min read
Save

Faricimab shows efficacy, safety and durability in treatment of wet AMD

Faricimab shows efficacy, safety and durability in treatment of wet AMD

Results at 48 weeks in the TENAYA and LUCERNE phase 3 trials showed positive outcomes of faricimab for neovascular age-related macular degeneration.

View more